AKT1 and breast carcinoma: Furthermore, CB2 receptor-mediated inhibition of Akt has been reported in ErbB2-positive breast cancer progression in mouse mammary tumour virus (MMTV)/neu transgenic mice as a syngeneic tumour model [45].